Crispr Offers New Hope for Treating Diabetes

Crispr Offers New Hope for Treating Diabetes

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.

CRISPR-Edited Cells Enable Insulin Production in Diabetes Patient Trial

In a groundbreaking advancement that could transform the lives of millions suffering from type 1 diabetes, researchers have successfully implanted gene-edited pancreatic cells into a patient, enabling the production of insulin without the need for lifelong injections or immunosuppressive drugs. This pioneering procedure, detailed in a recent report from Wired, marks the first time such hypoimmune cells have been tested in humans, offering a glim…